|
CLASP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.043710E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.499000E-03 |
| Normal-vs-Stage2 |
4.979500E-02 |
| Normal-vs-Stage3 |
1.019850E-04 |
| Normal-vs-Stage4 |
7.60690000000119E-05 |
| Stage1-vs-Stage2 |
7.288600E-01 |
| Stage1-vs-Stage3 |
9.195600E-02 |
| Stage1-vs-Stage4 |
6.252300E-02 |
| Stage2-vs-Stage3 |
1.208030E-01 |
| Stage2-vs-Stage4 |
9.467800E-02 |
| Stage3-vs-Stage4 |
8.410600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.440490E-03 |
| Normal-vs-AfricanAmerican |
1.067010E-01 |
| Normal-vs-Asian |
2.120400E-03 |
| Caucasian-vs-AfricanAmerican |
5.828600E-01 |
| Caucasian-vs-Asian |
7.309400E-01 |
| AfricanAmerican-vs-Asian |
4.596400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.163530E-03 |
| Normal-vs-Female |
1.860870E-03 |
| Male-vs-Female |
7.727400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.289630E-02 |
| Normal-vs-Age(41-60Yrs) |
8.378700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.801990E-04 |
| Normal-vs-Age(81-100Yrs) |
2.235300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.328800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.427230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.136180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.433600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.988590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.413400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.065900E-02 |
| Classical-VS-Follicular |
5.441900E-02 |
| Classical-VS-Other |
5.549400E-01 |
| Classical-VS-Normal |
1.363760E-02 |
| Tall-VS-Follicular |
4.759200E-01 |
| Tall-VS-Other |
6.160200E-01 |
| Tall-VS-Normal |
4.204300E-04 |
| Follicular-VS-Other |
9.496400E-01 |
| Follicular-VS-Normal |
1.503550E-03 |
| Other-VS-Normal |
1.054960E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.434980E-04 |
| Normal-vs-N1 |
2.823100E-04 |
| N0-vs-N1 |
5.980600E-01 |
|
|
